A carregar...
TOR-based therapy for cardiomyopathy: evidence from zebrafish and human studies
Rapamycin is an FDA approved drug for the prevention of immunorejection following organ transplantation. Pharmacological studies suggest a potential new application of rapamycin in attenuating cardiomyopathy, but the potential for this application is not yet supported by genetic studies of genes in...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440553/ https://ncbi.nlm.nih.gov/pubmed/22841839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tcm.2012.06.009 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|